CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study is a research paper published in Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 46 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA172404
Alberta Precision Laboratories
Grant: RS17‐601, RS10‐526
Cancer Research UK
Grant: 15601
NCI NIH HHS
Grant: R01 CA248288
NCI NIH HHS
Grant: P30 CA015083
NCI NIH HHS
Grant: P30 CA071789
NCI NIH HHS
Grant: P50 CA136393
NCI NIH HHS
Grant: R21 CA210210
NCI NIH HHS
Grant: R01 CA095023
NCI NIH HHS
Grant: U01 CA243483
NCI NIH HHS
Grant: N01 CA015083
NCI NIH HHS
Grant: R01 CA122443
NCI NIH HHS
Grant: R01 CA160669
NCATS NIH HHS
Grant: UL1 TR000124
NCI NIH HHS
Grant: R01 CA243511
Medical Research Council
Grant: MC_UU_00004/01
Evaluating new healthcare technologies in cancer
NCI NIH HHS
Grant: K07 CA080668
NCRR NIH HHS
Grant: M01 RR000056
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: P30 CA014089
Cancer Research UK
Grant: 22905
NCI NIH HHS
Grant: P30 CA047904
NCI NIH HHS
Grant: R01 CA243483
National Institutes of Health
Grant: 5R21CA210210-02
Targeting Cyclin E in Ovarian Cancer with Histone Deacetylase Inhibitors
National Institutes of Health
Grant: 5R01CA243483-04
Sequencing Familial Lung Cancer
National Health and Medical Research Council (NHMRC)
Grant: 400413
Australian Ovarian Cancer Study (AOCS): A multidisciplinary ovarian cancer resource for the genomic era
National Health and Medical Research Council (NHMRC)
Grant: 628903
Australasian Biospecimen Network - Oncology
National Institutes of Health
Grant: 3P30CA014089-17S1
USC COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
National Health and Medical Research Council (NHMRC)
Grant: 400281
Molecular Epidemiology of Ovarian Cancer: The Australian Ovarian Cancer Study National Clinical Follow-Up Core
National Institutes of Health
Grant: 5P50CA136393-10
Mayo Clinic Ovarian Cancer SPORE
National Institutes of Health
Grant: 5R01CA172404-05
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Health and Medical Research Council (NHMRC)
Grant: 310670
Australasian Biospecimen Network-Oncology
National Institutes of Health
Grant: 5R01CA095023-03
Inflammation and Ovarian Cancer
National Institutes of Health
Grant: 5UL1TR000124-04
UCLA Clinical and Translational Science Institute
National Institutes of Health
Grant: 5R01CA122443-06
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology
National Institutes of Health
Grant: 5R01CA160669-02
Mitochondrial DNA and Ovarian Cancer Risk and Survival
National Institutes of Health
Grant: 3R01CA243511-04S1
Epigenetic Drug Regimens for Homologous Recombination Proficient Ovarian Cancer - Diversity Supplement
National Institutes of Health
Grant: 3P30CA047904-07S1
CANCER CENTER SUPPORT GRANT
National Institutes of Health
Grant: 3P30CA015083-37S2
Mayo Comprehensive Cancer Center Grant
National Health and Medical Research Council (NHMRC)
Grant: 199600
Towards cancer control: Population and molecular strategies
National Institutes of Health
Grant: 5K07CA080668-06
OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS
FWCI
6.26
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals